28 research outputs found
Effect of the Novel Influenza A (H1N1) Virus in the Human Immune System
BACKGROUND: The pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in the immune system of the host. METHODOLOGY/PRINCIPAL FINDINGS: Blood was sampled within the first two days of the presentation of signs of infection from 10 healthy volunteers; from 18 cases of flu-like syndrome; and from 31 cases of infection by H1N1 confirmed by reverse RT-PCR. Absolute counts of subtypes of monocytes and of lymphocytes were determined after staining with monoclonal antibodies and analysis by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from patients and stimulated with various bacterial stimuli. Concentrations of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-18, interferon (FN)-alpha and of IFN-gamma were estimated in supernatants by an enzyme immunoassay. Infection by H1N1 was accompanied by an increase of monocytes. PBMCs of patients evoked strong cytokine production after stimulation with most of bacterial stimuli. Defective cytokine responses were shown in response to stimulation with phytohemagglutin and with heat-killed Streptococcus pneumoniae. Adaptive immune responses of H1N1-infected patients were characterized by decreases of CD4-lymphocytes and of B-lymphocytes and by increase of T-regulatory lymphocytes (Tregs). CONCLUSIONS/SIGNIFICANCE: Infection by the H1N1 virus is accompanied by a characteristic impairment of the innate immune responses characterized by defective cytokine responses to S.pneumoniae. Alterations of the adaptive immune responses are predominated by increase of Tregs. These findings signify a predisposition for pneumococcal infections after infection by H1N1 influenza
Detrimental effect of apoptosis of lymphocytes at an early time point of experimental abdominal sepsis
<p>Abstract</p> <p>Background</p> <p>Apoptosis of lymphocytes is considered a late sequelum in the sepsis cascade. The role of apoptosis of lymphocytes as a driver of final outcome was investigated.</p> <p>Methods</p> <p>Abdominal sepsis was induced after cecal ligation and puncture (CLP) in 31 rabbits. Blood was sampled at serial time intervals and peripheral blood mononuclear cells (PBMCs) were isolated. Apoptosis of lymphocytes and monocytes was measured through flow cytometric analysis. PBMCs were stimulated with LPS and Pam3Cys for the release of tumor necrosis factor-alpha (TNFα). Tissue bacterial growth was quantitatively measured. In a second set of experiments, CLP was performed in another 40 rabbits; 20 received single intravenous infusions of ciprofloxacin and of metronidazole 4 hours after surgery.</p> <p>Results</p> <p>Animals were divided into two groups based on the percentage of lymphocyte apoptosis at 4 hours after surgery; less than or equal to 32% and more than 32%. Survival of the former was shorter than the latter (p: 0.017). Tissue growth was similar between groups. Apoptosis of lymphocytes and of monocytes was lower in the former group over follow-up. Release of ΤNFα did not differ. The above findings on survival were repeated in the second set of experiments. Administration of antimicrobials prolonged survival of the former group (p: 0.039) but not of the latter group (pNS).</p> <p>Conclusions</p> <p>Lymphocyte apoptosis at an early time point of experimental peritonitis is a major driver for death. A lower percentage of apoptosis leads earlier to death. Antimicrobials were beneficial even at that disease state.</p
Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial
Objective:
To evaluate the long-term efficacy of etanercept for the management of
hidradenitis suppurativa.
Methods:
Analysis was based on the long-term follow-up (weeks 24-144) of 10
patients enrolled in a prospective open-label phase II study; etanercept
was initially administered subcutaneously 50 mg once weekly for 12 weeks
in 10 patients. Disease recurrence and the need to restart etanercept
were recorded.
Results:
Three patients did not report any disease recurrence. A second course of
treatment with etanercept was needed in seven patients. Favourable
responses were found in five; two patients failed treatment.
Conclusions:
The first treatment course achieved long-term disease remission in
almost one-third of patients. The remaining needed a second treatment
course but even in that case, their disease severity at restart was
significantly lower compared with baseline
Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection
Objectives: To identify the role of single nucleotide polymorphisms
(SNPs) of the tumor necrosis factor (TNF) gene in the natural course of
2009 influenza A H1N1 virus infection.
Methods: Genomic DNA was isolated from 109 patients with an H1N1
infection and from 108 healthy volunteers. SNPs of the TNF gene were
assessed after electrophoresis of the digested PCR products by
restriction enzymes.
Results: The frequency of the -238 A allele was significantly greater
among patients than among controls. Viral pneumonia developed in 20 of
96 non-carriers of at least one -238 A allele (20.8%) and in seven of
13 carriers of at least one -238 A allele (53.8%, p = 0.016). Logistic
regression analysis showed that the most important factors associated
with the development of pneumonia were the presence of an underlying
disease (p = 0.021, odds ratio (OR) 3.08) and the carriage of at least
one -238 A allele (p = 0.041, OR 3.74). Gene transcripts of the TNF gene
were greater among non-carriers of the -238 A allele than among carriers
of the -238 A allele.
Conclusions: The -238 A SNP allele of the TNF gene imposes on the course
of 2009 H1N1 virus infection and is an independent risk factor for
pneumonia. (C) 2012 International Society for Infectious Diseases.
Published by Elsevier Ltd. All rights reserved
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis
Pneumococcal meningitis is the most frequent and critical type of bacterial meningitis. Because cytokines play an important role in the pathogenesis of bacterial meningitis, we examined whether functional polymorphisms of the proinflammatory cytokine macrophage migration inhibitory factor (MIF) were associated with morbidity and mortality of pneumococcal meningitis. Two functional MIF promoter polymorphisms, a microsatellite (-794 CATT5-8; rs5844572) and a single-nucleotide polymorphism (-173 G/C; rs755622) were genotyped in a prospective, nationwide cohort of 405 patients with pneumococcal meningitis and in 329 controls matched for age, gender, and ethnicity. Carriages of the CATT7 and -173 C high-expression MIF alleles were associated with unfavorable outcome (P= 0.005 and 0.003) and death (P= 0.03 and 0.01). In a multivariate logistic regression model, shock [odds ratio (OR) 26.0, P= 0.02] and carriage of the CATT7 allele (OR 5.12,P= 0.04) were the main predictors of mortality. MIF levels in the cerebrospinal fluid were associated with systemic complications and death (P= 0.0002). Streptococcus pneumoniae strongly up-regulated MIF production in whole blood and transcription activity of high-expression MIF promoter Luciferase reporter constructs in THP-1 monocytes. Consistent with these findings, treatment with anti-MIF immunoglogulin G (IgG) antibodies reduced bacterial loads and improved survival in a mouse model of pneumococcal pneumonia and sepsis. The present study provides strong evidence that carriage of high-expression MIF alleles is a genetic marker of morbidity and mortality of pneumococcal meningitis and also suggests a potential role for MIF as a target of immune-modulating adjunctive therap
Stimulation of IL-10 and IL-17 in relation with disease severity
<p>Production of IL-10 and IL-17 was stimulated in peripheral blood mononuclear cells (PBMCs) of patients with hidradenitis suppurativa (HS) by LPS of <i>Escherichia coli</i> O55:B5, heat-killed <i>Candida albicans</i> (HKCA) and heat-killed <i>Staphylococcus aureus</i> (HKSA). Patients are divided into those with Hurley I or Hurley II disease stage (n = 50) and into those with Hurley III disease stage (n = 40). P values refer to comparisons between disease stages by the Mann Whitney U test; pNS: difference not-significant.</p